{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:36:43Z","timestamp":1792165003599,"version":"4.4.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,12,17]],"date-time":"2008-12-17T00:00:00Z","timestamp":1229472000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1038\/ejhg.2008.212","type":"journal-article","created":{"date-parts":[[2008,12,17]],"date-time":"2008-12-17T13:38:08Z","timestamp":1229521088000},"page":"722-731","source":"Crossref","is-referenced-by-count":159,"title":["Breast cancer susceptibility: current knowledge and implications for genetic counselling"],"prefix":"10.1038","volume":"17","author":[{"given":"Tim","family":"Ripperger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Gadzicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfons","family":"Meindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Schlegelberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,12,17]]},"reference":[{"key":"BFejhg2008212_CR1","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMcp071286","volume":"357","author":"M Robson","year":"2007","unstructured":"Robson M, Offit K : Clinical practice. Management of an inherited predisposition to breast cancer. N Engl J Med 2007; 357: 154\u2013162.","journal-title":"N Engl J Med"},{"key":"BFejhg2008212_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11154-007-9038-0","volume":"8","author":"AR Bradbury","year":"2007","unstructured":"Bradbury AR, Olopade OI : Genetic susceptibility to breast cancer. Rev Endocr Metab Disord 2007; 8: 255\u2013267.","journal-title":"Rev Endocr Metab Disord"},{"key":"BFejhg2008212_CR3","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1056\/NEJMra012284","volume":"348","author":"R Wooster","year":"2003","unstructured":"Wooster R, Weber BL : Breast and ovarian cancer. N Engl J Med 2003; 348: 2339\u20132347.","journal-title":"N Engl J Med"},{"key":"BFejhg2008212_CR4","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/87876","volume":"7","author":"KL Nathanson","year":"2001","unstructured":"Nathanson KL, Wooster R, Weber BL : Breast cancer genetics: what we know and what we need. Nat Med 2001; 7: 552\u2013556.","journal-title":"Nat Med"},{"key":"BFejhg2008212_CR5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/ijc.1626","volume":"97","author":"A Meindl","year":"2002","unstructured":"Meindl A : Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. Int J Cancer 2002; 97: 472\u2013480.","journal-title":"Int J Cancer"},{"key":"BFejhg2008212_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev.genom.9.081307.164339","volume":"9","author":"C Turnbull","year":"2008","unstructured":"Turnbull C, Rahman N : Genetic predisposition to breast cancer: past, present, and future. Annu Rev Genomics Hum Genet 2008; 9: 321\u2013345.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"BFejhg2008212_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng.2007.53","volume":"40","author":"MR Stratton","year":"2008","unstructured":"Stratton MR, Rahman N : The emerging landscape of breast cancer susceptibility. Nat Genet 2008; 40: 17\u201322.","journal-title":"Nat Genet"},{"key":"BFejhg2008212_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1399-0004.2007.00909.x","volume":"72","author":"PJ Willems","year":"2007","unstructured":"Willems PJ : Susceptibility genes in breast cancer: more is less? Clin Genet 2007; 72: 493\u2013496.","journal-title":"Clin Genet"},{"key":"BFejhg2008212_CR9","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1200\/JCO.2003.03.189","volume":"21","author":"American Society of Clinical Oncology","year":"2003","unstructured":"American Society of Clinical Oncology: American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 2003; 21: 2397\u20132406.","journal-title":"J Clin Oncol"},{"key":"BFejhg2008212_CR10","first-page":"A1396","volume":"95","author":"K Bachmann","year":"1998","unstructured":"Bachmann K, Bartram CR, Chang-Claude J, Fonatsch C, Propping P : Richtlinien zur Diagnostik der genetischen Disposition f\u00fcr Krebserkrankungen. Deutsches \u00c4rzteblatt 1998; 95: A1396\u2013A1403.","journal-title":"Deutsches \u00c4rzteblatt"},{"key":"BFejhg2008212_CR11","first-page":"A1297","volume":"100","author":"M Dietel","year":"2003","unstructured":"Dietel M, Harms E, Honnefelder L et al: Bekanntmachungen: Richtlinien zur pr\u00e4diktiven genetischen Diagnostik. Deutsches \u00c4rzteblatt 2003; 100: A1297\u2013A1305.","journal-title":"Deutsches \u00c4rzteblatt"},{"key":"BFejhg2008212_CR12","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1055\/s-2003-44815","volume":"125","author":"R Schmutzler","year":"2003","unstructured":"Schmutzler R, Schlegelberger B, Meindl A, Gerber WD, Kiechle M : [Counselling, genetic testing and prevention in women with hereditary breast- and ovarian cancer. Interdisciplinary recommendations of the consortium \u2018Hereditary Breast- and Ovarian Cancer\u2019 of the German Cancer AiD]. Zentralbl Gynakol 2003; 125: 494\u2013506.","journal-title":"Zentralbl Gynakol"},{"key":"BFejhg2008212_CR13","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1023\/A:1008389021382","volume":"9","author":"F Eisinger","year":"1998","unstructured":"Eisinger F, Alby N, Bremond A et al: Recommendations for medical management of hereditary breast and ovarian cancer: the French National ad hoc Committee. Ann Oncol 1998; 9: 939\u2013950.","journal-title":"Ann Oncol"},{"key":"BFejhg2008212_CR14","volume-title":"Clinical Guidelines and Evidence Review for the Classification and Care of Women at Risk of Familial Breast Cancer (NICE Guidelines CG014)","author":"A McIntosh","year":"2004","unstructured":"McIntosh A, Shaw C, Evans G et al: Clinical Guidelines and Evidence Review for the Classification and Care of Women at Risk of Familial Breast Cancer (NICE Guidelines CG014). London: National Collaborating Centre for Primary Care, University of Sheffield, 2004."},{"key":"BFejhg2008212_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10689-007-9151-y","volume":"6","author":"F Guenard","year":"2007","unstructured":"Guenard F, Labrie Y, Ouellette G et al: Germline mutations in the breast cancer susceptibility gene PTEN are rare in high-risk non-BRCA1\/2 French Canadian breast cancer families. Fam Cancer 2007; 6: 483\u2013490.","journal-title":"Fam Cancer"},{"key":"BFejhg2008212_CR16","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1001\/jama.297.21.2360","volume":"297","author":"P Kaurah","year":"2007","unstructured":"Kaurah P, MacMillan A, Boyd N et al: Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 2007; 297: 2360\u20132372.","journal-title":"JAMA"},{"key":"BFejhg2008212_CR17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/jmg.2007.049346","volume":"44","author":"S Sharif","year":"2007","unstructured":"Sharif S, Moran A, Huson SM et al: Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening. J Med Genet 2007; 44: 481\u2013484.","journal-title":"J Med Genet"},{"key":"BFejhg2008212_CR18","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/ijc.23168","volume":"122","author":"N Bogdanova","year":"2007","unstructured":"Bogdanova N, Feshchenko S, Schurmann P et al: Nijmegen breakage syndrome mutations and risk of breast cancer. Int J Cancer 2007; 122: 802\u2013806.","journal-title":"Int J Cancer"},{"key":"BFejhg2008212_CR19","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1158\/1078-0432.CCR-06-0083","volume":"12","author":"N Hearle","year":"2006","unstructured":"Hearle N, Schumacher V, Menko FH et al: Frequency and spectrum of cancers in the Peutz\u2013Jeghers syndrome. Clin Cancer Res 2006; 12: 3209\u20133215.","journal-title":"Clin Cancer Res"},{"key":"BFejhg2008212_CR20","first-page":"6094","volume":"51","author":"JE Garber","year":"1991","unstructured":"Garber JE, Goldstein AM, Kantor AF, Dreyfus MG, Fraumeni Jr JF, Li FP : Follow-up study of twenty-four families with Li\u2013Fraumeni syndrome. Cancer Res 1991; 51: 6094\u20136097.","journal-title":"Cancer Res"},{"key":"BFejhg2008212_CR21","unstructured":"NCCN Clinical Practice Guidelines in Oncology: Genetic\/familial high risk assessment: breast and ovarian. Version I. 2008, \n                    www.nccn.org\/professionals\/physician_gls\/PDF\/genetics_screening.pdf\n                    \n                  ."},{"key":"BFejhg2008212_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10689-007-9165-5","volume":"7","author":"HT Lynch","year":"2008","unstructured":"Lynch HT, Lynch JF, Lynch PM, Attard T : Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management. Fam Cancer 2008; 7: 27\u201339.","journal-title":"Fam Cancer"},{"key":"BFejhg2008212_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/ng.2007.39","volume":"40","author":"LH Saal","year":"2008","unstructured":"Saal LH, Gruvberger-Saal SK, Persson C et al: Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nat Genet 2008; 40: 102\u2013107.","journal-title":"Nat Genet"},{"key":"BFejhg2008212_CR24","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1136\/jmg.2007.051268","volume":"44","author":"S Masciari","year":"2007","unstructured":"Masciari S, Larsson N, Senz J et al: Germline E-cadherin mutations in familial lobular breast cancer. J Med Genet 2007; 44: 726\u2013731.","journal-title":"J Med Genet"},{"key":"BFejhg2008212_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10689-007-9172-6","volume":"7","author":"KA Schrader","year":"2008","unstructured":"Schrader KA, Masciari S, Boyd N et al: Hereditary diffuse gastric cancer: association with lobular breast cancer. Fam Cancer 2008; 7: 73\u201382.","journal-title":"Fam Cancer"},{"key":"BFejhg2008212_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ccr.2007.01.010","volume":"11","author":"T Walsh","year":"2007","unstructured":"Walsh T, King MC : Ten genes for inherited breast cancer. Cancer Cell 2007; 11: 103\u2013105.","journal-title":"Cancer Cell"},{"key":"BFejhg2008212_CR27","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1086\/320610","volume":"68","author":"HF Vasen","year":"2001","unstructured":"Vasen HF, Morreau H, Nortier JW : Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer? Am J Hum Genet 2001; 68: 1533\u20131535.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2008212_CR28","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/(SICI)1097-0142(19960501)77:9<1836::AID-CNCR12>3.0.CO;2-0","volume":"77","author":"JI Risinger","year":"1996","unstructured":"Risinger JI, Barrett JC, Watson P, Lynch HT, Boyd J : Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer 1996; 77: 1836\u20131843.","journal-title":"Cancer"},{"key":"BFejhg2008212_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10689-007-9164-6","volume":"7","author":"J Geary","year":"2008","unstructured":"Geary J, Sasieni P, Houlston R et al: Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC). Fam Cancer 2008; 7: 163\u2013172.","journal-title":"Fam Cancer"},{"key":"BFejhg2008212_CR30","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/ijc.23508","volume":"123","author":"P Watson","year":"2008","unstructured":"Watson P, Vasen HF, Mecklin JP et al: The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer 2008; 123: 444\u2013449.","journal-title":"Int J Cancer"},{"key":"BFejhg2008212_CR31","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1001\/jama.296.12.1507","volume":"296","author":"NM Lindor","year":"2006","unstructured":"Lindor NM, Petersen GM, Hadley DW et al: Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006; 296: 1507\u20131517.","journal-title":"JAMA"},{"key":"BFejhg2008212_CR32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/jmg.2007.048991","volume":"44","author":"HF Vasen","year":"2007","unstructured":"Vasen HF, Moslein G, Alonso A et al: Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 2007; 44: 353\u2013362.","journal-title":"J Med Genet"},{"key":"BFejhg2008212_CR33","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/sj.ejhg.5201860","volume":"15","author":"NG Howlett","year":"2007","unstructured":"Howlett NG : Fanconi anemia: Fanconi anemia, breast and embryonal cancer risk revisited. Eur J Hum Genet 2007; 15: 715\u2013717.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg2008212_CR34","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nrg2159","volume":"8","author":"W Wang","year":"2007","unstructured":"Wang W : Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet 2007; 8: 735\u2013748.","journal-title":"Nat Rev Genet"},{"key":"BFejhg2008212_CR35","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/emboj.2008.15","volume":"27","author":"R Hakem","year":"2008","unstructured":"Hakem R : DNA-damage repair; the good, the bad, and the ugly. EMBO J 2008; 27: 589\u2013605.","journal-title":"EMBO J"},{"key":"BFejhg2008212_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nrc970","volume":"3","author":"AD D\u2019Andrea","year":"2003","unstructured":"D\u2019Andrea AD, Grompe M : The Fanconi anaemia\/BRCA pathway. Nat Rev Cancer 2003; 3: 23\u201334.","journal-title":"Nat Rev Cancer"},{"key":"BFejhg2008212_CR37","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/ng1837","volume":"38","author":"A Renwick","year":"2006","unstructured":"Renwick A, Thompson D, Seal S et al: ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 2006; 38: 873\u2013875.","journal-title":"Nat Genet"},{"key":"BFejhg2008212_CR38","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/ng1902","volume":"38","author":"S Seal","year":"2006","unstructured":"Seal S, Thompson D, Renwick A et al: Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 2006; 38: 1239\u20131241.","journal-title":"Nat Genet"},{"key":"BFejhg2008212_CR39","doi-asserted-by":"publisher","first-page":"5912","DOI":"10.1038\/sj.onc.1209877","volume":"25","author":"H Nevanlinna","year":"2006","unstructured":"Nevanlinna H, Bartek J : The CHEK2 gene and inherited breast cancer susceptibility. Oncogene 2006; 25: 5912\u20135919.","journal-title":"Oncogene"},{"key":"BFejhg2008212_CR40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/ng1959","volume":"39","author":"N Rahman","year":"2007","unstructured":"Rahman N, Seal S, Thompson D et al: PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 2007; 39: 165\u2013167.","journal-title":"Nat Genet"},{"key":"BFejhg2008212_CR41","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/carcin\/bgi360","volume":"27","author":"K Heikkinen","year":"2006","unstructured":"Heikkinen K, Rapakko K, Karppinen SM et al: RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability. Carcinogenesis 2006; 27: 1593\u20131599.","journal-title":"Carcinogenesis"},{"key":"BFejhg2008212_CR42","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/ng2075","volume":"39","author":"DJ Hunter","year":"2007","unstructured":"Hunter DJ, Kraft P, Jacobs KB et al: A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007; 39: 870\u2013874.","journal-title":"Nat Genet"},{"key":"BFejhg2008212_CR43","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/nature05887","volume":"447","author":"DF Easton","year":"2007","unstructured":"Easton DF, Pooley KA, Dunning AM et al: Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007; 447: 1087\u20131093.","journal-title":"Nature"},{"key":"BFejhg2008212_CR44","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ng1981","volume":"39","author":"A Cox","year":"2007","unstructured":"Cox A, Dunning AM, Garcia-Closas M et al: A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 2007; 39: 352\u2013358.","journal-title":"Nat Genet"},{"key":"BFejhg2008212_CR45","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/ng2064","volume":"39","author":"SN Stacey","year":"2007","unstructured":"Stacey SN, Manolescu A, Sulem P et al: Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2007; 39: 865\u2013869.","journal-title":"Nat Genet"},{"key":"BFejhg2008212_CR46","doi-asserted-by":"publisher","first-page":"5906","DOI":"10.1038\/sj.onc.1209873","volume":"25","author":"M Ahmed","year":"2006","unstructured":"Ahmed M, Rahman N : ATM and breast cancer susceptibility. Oncogene 2006; 25: 5906\u20135911.","journal-title":"Oncogene"},{"key":"BFejhg2008212_CR47","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1383-5742(00)00034-X","volume":"462","author":"S Angele","year":"2000","unstructured":"Angele S, Hall J : The ATM gene and breast cancer: is it really a risk factor? Mutat Res 2000; 462: 167\u2013178.","journal-title":"Mutat Res"},{"key":"BFejhg2008212_CR48","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1002\/ijc.23026","volume":"121","author":"DW Bell","year":"2007","unstructured":"Bell DW, Kim SH, Godwin AK et al: Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts. Int J Cancer 2007; 121: 2661\u20132667.","journal-title":"Int J Cancer"},{"key":"BFejhg2008212_CR49","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1200\/JCO.2007.12.5922","volume":"26","author":"M Weischer","year":"2008","unstructured":"Weischer M, Bojesen SE, Ellervik C, Tybjaerg-Hansen A, Nordestgaard BG : CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26\u2009000 patient cases and 27\u2009000 controls. J Clin Oncol 2008; 26: 542\u2013548.","journal-title":"J Clin Oncol"},{"key":"BFejhg2008212_CR50","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/ijc.11414","volume":"108","author":"A Osorio","year":"2004","unstructured":"Osorio A, Rodriguez-Lopez R, Diez O et al: The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population. Int J Cancer 2004; 108: 54\u201356.","journal-title":"Int J Cancer"},{"key":"BFejhg2008212_CR51","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/ijc.20073","volume":"110","author":"MR Dufault","year":"2004","unstructured":"Dufault MR, Betz B, Wappenschmidt B et al: Limited relevance of the CHEK2 gene in hereditary breast cancer. Int J Cancer 2004; 110: 320\u2013325.","journal-title":"Int J Cancer"},{"key":"BFejhg2008212_CR52","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1200\/JCO.2006.06.3024","volume":"25","author":"MK Schmidt","year":"2007","unstructured":"Schmidt MK, Tollenaar RA, de Kemp SR et al: Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation. J Clin Oncol 2007; 25: 64\u201369.","journal-title":"J Clin Oncol"},{"key":"BFejhg2008212_CR53","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1200\/JCO.2007.13.8503","volume":"26","author":"K Offit","year":"2008","unstructured":"Offit K, Garber JE : Time to check CHEK2 in families with breast cancer? J Clin Oncol 2008; 26: 519\u2013520.","journal-title":"J Clin Oncol"},{"key":"BFejhg2008212_CR54","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ng879","volume":"31","author":"H Meijers-Heijboer","year":"2002","unstructured":"Meijers-Heijboer H, van den OA, Klijn J et al: Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 2002; 31: 55\u201359.","journal-title":"Nat Genet"},{"key":"BFejhg2008212_CR55","doi-asserted-by":"publisher","first-page":"R27","DOI":"10.1186\/bcr1669","volume":"9","author":"C Baynes","year":"2007","unstructured":"Baynes C, Healey CS, Pooley KA et al: Common variants in the ATM BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk. Breast Cancer Res 2007; 9: R27.","journal-title":"Breast Cancer Res"},{"key":"BFejhg2008212_CR56","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/35015718","volume":"405","author":"NJ Risch","year":"2000","unstructured":"Risch NJ : Searching for genetic determinants in the new millennium. Nature 2000; 405: 847\u2013856.","journal-title":"Nature"},{"key":"BFejhg2008212_CR57","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/ejhg.2008.12","volume":"16","author":"KC Seng","year":"2008","unstructured":"Seng KC, Seng CK : The success of the genome-wide association approach: a brief story of a long struggle. Eur J Hum Genet 2008; 16: 554\u2013564.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg2008212_CR58","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1155\/2001\/981218","volume":"22","author":"M Heiskanen","year":"2001","unstructured":"Heiskanen M, Kononen J, Barlund M et al: CGH cDNA and tissue microarray analyses implicate FGFR2 amplification in a small subset of breast tumors. Anal Cell Pathol 2001; 22: 229\u2013234.","journal-title":"Anal Cell Pathol"},{"key":"BFejhg2008212_CR59","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1073\/pnas.0800441105","volume":"105","author":"B Gold","year":"2008","unstructured":"Gold B, Kirchhoff T, Stefanov S et al: Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci USA 2008; 105: 4340\u20134345.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFejhg2008212_CR60","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1371\/journal.pbio.0060108","volume":"6","author":"KB Meyer","year":"2008","unstructured":"Meyer KB, Maia AT, O\u2019Reilly M et al: Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer. PLoS Biol 2008; 6: e108.","journal-title":"PLoS Biol"},{"key":"BFejhg2008212_CR61","doi-asserted-by":"publisher","first-page":"5898","DOI":"10.1038\/sj.onc.1209879","volume":"25","author":"AC Antoniou","year":"2006","unstructured":"Antoniou AC, Easton DF : Models of genetic susceptibility to breast cancer. Oncogene 2006; 25: 5898\u20135905.","journal-title":"Oncogene"},{"key":"BFejhg2008212_CR62","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1136\/jmg.2006.043091","volume":"44","author":"A Smith","year":"2007","unstructured":"Smith A, Moran A, Boyd MC et al: Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening. J Med Genet 2007; 44: 10\u201315.","journal-title":"J Med Genet"},{"key":"BFejhg2008212_CR63","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/bcr1670","volume":"9","author":"G Chenevix-Trench","year":"2007","unstructured":"Chenevix-Trench G, Milne RL, Antoniou AC, Couch FJ, Easton DF, Goldgar DE : An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Breast Cancer Res 2007; 9: 104.","journal-title":"Breast Cancer Res"},{"key":"BFejhg2008212_CR64","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1038\/sj.bjc.6601837","volume":"90","author":"L Kadouri","year":"2004","unstructured":"Kadouri L, Kote-Jarai Z, Hubert A et al: A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers. Br J Cancer 2004; 90: 2002\u20132005.","journal-title":"Br J Cancer"},{"key":"BFejhg2008212_CR65","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1086\/522611","volume":"81","author":"AC Antoniou","year":"2007","unstructured":"Antoniou AC, Sinilnikova OM, Simard J et al: RAD51 135G \u2192 C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet 2007; 81: 1186\u20131200.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2008212_CR66","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.ajhg.2008.02.008","volume":"82","author":"AC Antoniou","year":"2008","unstructured":"Antoniou AC, Spurdle AB, Sinilnikova OM et al: Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 2008; 82: 937\u2013948.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2008212_CR67","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nrc1431","volume":"4","author":"SA Narod","year":"2004","unstructured":"Narod SA, Foulkes WD : BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 2004; 4: 665\u2013676.","journal-title":"Nat Rev Cancer"},{"key":"BFejhg2008212_CR68","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/jmg.2003.013623","volume":"41","author":"F Marroni","year":"2004","unstructured":"Marroni F, Aretini P, D\u2019Andrea E et al: Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations. J Med Genet 2004; 41: 278\u2013285.","journal-title":"J Med Genet"},{"key":"BFejhg2008212_CR69","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1200\/JCO.2005.02.2368","volume":"24","author":"CH Barcenas","year":"2006","unstructured":"Barcenas CH, Hosain GM, Arun B et al: Assessing BRCA carrier probabilities in extended families. J Clin Oncol 2006; 24: 354\u2013360.","journal-title":"J Clin Oncol"},{"key":"BFejhg2008212_CR70","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/sj.bjc.6604305","volume":"98","author":"AC Antoniou","year":"2008","unstructured":"Antoniou AC, Cunningham AP, Peto J et al: The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer 2008; 98: 1457\u20131466.","journal-title":"Br J Cancer"},{"key":"BFejhg2008212_CR71","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1524-4741.2007.00516.x","volume":"14","author":"E Silva","year":"2008","unstructured":"Silva E, Gatalica Z, Snyder C, Vranic S, Lynch JF, Lynch HT : Hereditary breast cancer: part II. Management of hereditary breast cancer: implications of molecular genetics and pathology. Breast J 2008; 14: 14\u201324.","journal-title":"Breast J"},{"key":"BFejhg2008212_CR72","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ng879","volume":"31","author":"H Meijers-Heijboer","year":"2002","unstructured":"Meijers-Heijboer H, van den OA, Klijn J et al: Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 2002; 31: 55\u201359.","journal-title":"Nat Genet"},{"key":"BFejhg2008212_CR73","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1200\/JCO.2007.11.4223","volume":"25","author":"N Bogdanova","year":"2007","unstructured":"Bogdanova N, Feshchenko S, Cybulski C, Dork T : CHEK2 mutation and hereditary breast cancer. J Clin Oncol 2007; 25: e26.","journal-title":"J Clin Oncol"},{"key":"BFejhg2008212_CR74","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nature05609","volume":"446","author":"H Erkko","year":"2007","unstructured":"Erkko H, Xia B, Nikkila J et al: A recurrent mutation in PALB2 in Finnish cancer families. Nature 2007; 446: 316\u2013319.","journal-title":"Nature"},{"key":"BFejhg2008212_CR75","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1056\/NEJMsa0708739","volume":"358","author":"PD Pharoah","year":"2008","unstructured":"Pharoah PD, Antoniou AC, Easton DF, Ponder BA : Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med 2008; 358: 2796\u20132803.","journal-title":"N Engl J Med"},{"key":"BFejhg2008212_CR76","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/sj.ejhg.5201484","volume":"13","author":"JJ Cassiman","year":"2005","unstructured":"Cassiman JJ : Research network: EuroGentest \u2013 a European Network of Excellence aimed at harmonizing genetic testing services. Eur J Hum Genet 2005; 13: 1103\u20131105.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg2008212_CR77","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/ejhg.2008.115","volume":"16","author":"GS Ginsburg","year":"2008","unstructured":"Ginsburg GS : Genomic medicine: \u2018grand challenges\u2019 in the translation of genomics to human health. Eur J Hum Genet 2008; 16: 873\u2013874.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg2008212_CR78","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1001\/jama.299.11.1320","volume":"299","author":"MT Scheuner","year":"2008","unstructured":"Scheuner MT, Sieverding P, Shekelle PG : Delivery of genomic medicine for common chronic adult diseases: a systematic review. JAMA 2008; 299: 1320\u20131334.","journal-title":"JAMA"},{"key":"BFejhg2008212_CR79","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/ng.155","volume":"40","author":"R Fagerholm","year":"2008","unstructured":"Fagerholm R, Hofstetter B, Tommiska J et al: NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer. Nat Genet 2008; 40: 844\u2013853.","journal-title":"Nat Genet"},{"key":"BFejhg2008212_CR80","doi-asserted-by":"publisher","first-page":"e1000054","DOI":"10.1371\/journal.pgen.1000054","volume":"4","author":"M Garcia-Closas","year":"2008","unstructured":"Garcia-Closas M, Hall P, Nevanlinna H et al: Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet 2008; 4: e1000054.","journal-title":"PLoS Genet"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg2008212.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2008212","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2008212.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T16:55:59Z","timestamp":1684428959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg2008212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,17]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["BFejhg2008212"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2008.212","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,17]]}}}